(Q42461978)

1 November 2017

title

Effect of losartan on afferent nerve stimulation (English)

1 reference

1 November 2017

1 reference

Damase-Michel C

1

1 reference

1 November 2017

Tran MA

series ordinal

2

1 reference

1 November 2017

Montastruc JL

series ordinal

3

1 reference

1 November 2017

Montastruc P

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

European Journal of Pharmacology

1 November 2017

published in

1 reference

1 November 2017

volume

355

1 reference

1 November 2017

issue

2-3

1 reference

1 November 2017

page(s)

125-132

1 reference

Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Effects of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, MET-enkephalin and catecholamines from dog adrenal medulla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Pharmacology of chronic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Role of AT1 receptors in the central control of sympathetic vasomotor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Integrative neural cardiovascular control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Angiotensin II receptor inhibition. A new therapeutic principle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Potentiation by naloxone of pressor reflexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Neurohypophysial peptides and central cardiovascular control in the anaesthetized dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Reduction of vagal pressor reflexes by neurohypophyseal peptides and related compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Release of neuropeptide Y and noradrenaline during afferent nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Vagal sensory receptors and their reflex effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Somatosympathetic reflexes: afferent fibers, central pathways, discharge characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Access of peripherally administered DuP 753 to rat brain angiotensin II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

Effects of the Nonpeptide Angiotensin II Receptor Antagonist DuP 753 on Blood Pressure and Renal Functions in Spontaneously Hypertensive PH Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900488-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00488-9

1 reference

1 November 2017

1 reference